NCT02723994 2026-03-11A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic LeukemiaIncyte CorporationPhase 2 Completed171 enrolled
NCT01397825 2018-03-27MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- VincristineTakedaPhase 1/2 Completed45 enrolled 24 charts